株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

開業医・グループ診断向け診断検査市場:サプライヤーシェアと売上高予測

2016 Physician Office/Group Practice Diagnostic Testing Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review

発行 Venture Planning Group 商品コード 323313
出版日 ページ情報 英文 970 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

Local License: 同一事業所内

Back to Top
開業医・グループ診断向け診断検査市場:サプライヤーシェアと売上高予測 2016 Physician Office/Group Practice Diagnostic Testing Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 300 Tests, Technology Trends, Instrumentation Review
出版日: ページ情報: 英文 970 Pages
概要

当レポートでは、開業医・グループ診断向け診断検査市場について調査分析し、市場動向、規模、成長率、規制要件、技術動向、競合情勢、装置・消耗品サプライヤーの新興の機会などについて、体系的な情報を提供しています。

イントロダクション

検査の分散化の合理的根拠

世界市場と技術の概要

  • 主な定期的化学検査(全30種)
  • 感染症検査(全33種)
  • 腫瘍マーカー(全5種)
  • 主な定期的・特殊血液検査(全1種)
  • 内分泌機能検査(全13種)
  • 薬物治療モニタリング(TDM)(全11種)
  • 血液凝固検査(全13種)
  • 免疫タンパク質検査(全2種)
  • 薬物乱用検査(全12種)
  • 検査装置
    • 化学分析装置
    • 血液分析装置
    • 血液凝固分析装置
  • 既存/将来の技術
    • モノクローナル抗体
    • イムノアッセイ(免疫測定法)
    • ドライケミストリー
    • バイオセンサー
    • IT・オートメーション
    • 分子診断

世界のビジネス環境

米国

  • 市場概要
    • ビジネス環境
    • 市場構造
  • 開業医/グループ検診
    • 市場概要
    • 市場構造
    • 検査件数と売上高予測
  • 主要サプライヤーの装置設置、設置ベース、消耗品売上高と市場シェア

主な製品開発の機会

  • 定期的・特殊化学
  • 微生物/感染症
  • 血液・フローサイトメトリー
  • 血液凝固

分散型検査製品の設計基準

代替的な市場普及戦略

  • 自社開発
  • 共同開発
  • 大学との提携
  • 分散型検査市場の流通戦略

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競合
  • 技術面での優位性と限界
  • 特許保護
  • 規制上の制約
  • 分散型検査市場の課題

企業プロファイル

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • 栄研化学
  • EKF Diagnostics
  • 富士レビオ/Innogenetics
  • Helena Laboratories
  • Hologic/Gen-Probe
  • 堀場製作所
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • 日本光電
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • シスメックス
  • タカラバイオ
  • ThermoFisher
  • 東ソー
  • 和光純薬工業
  • Zycare/Alere

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPPOC20954

This 970-page report provides a comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

This report will help diagnostic reagent and instrument suppliers develop more effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the physician office/group practice diagnostics market, including its dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures, including:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for physician office/group practice diagnostic testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next ten years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 970 pages and 152 tables

 

Table of Contents

Introduction

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

  • A. Major Routine Chemistry Tests
    • 1. Albumin
    • 2. Alkaline Phosphatase
    • 3. ALT/SGPT
    • 4. Ammonia
    • 5. Amylase
    • 6. AST/SGOT
    • 7. Bilirubin
    • 8. Blood Gases
    • 9. Blood Urea Nitrogen (BUN)
    • 10. Calcium
    • 11. Cholesterol
    • 12. Cholinesterase
    • 13. Creatinine
    • 14. Electrolytes
      • a. Carbon Dioxide/Bicarbonate
      • b. Chloride
      • c. Potassium
      • d. Sodium
    • 15. Ferritin
    • 16. Follate/Folic Acid
    • 17. Fructosamine
    • 18. Gamma-Glutamyl Transpeptidase (GGT)
    • 19. Glucose
    • 20. High Density Lipoprotein (HDL)
    • 21. Iron
    • 22. Lactate Dehydrogenase (LDH)
    • 23. Magnesium
    • 24. Phosphorus
    • 25. Protein
    • 26. Triglycerides
    • 27. Troponin
    • 28. Uric Acid
    • 29. Urinalysis
    • 30. Vitamin B12

Infectious Disease Tests

  • 1. AIDS
  • 2. Adenovirus
  • 3. Campylobacter
  • 4. Candida
  • 5. Chlamydia
  • 6. Clostridium Difficile
  • 7. Cytomegalovirus
  • 8. Enteroviruses
  • 9. Epstein-Barr Virus
  • 10. Gonorrhea
  • 11. Helicobacter Pylori
  • 12. Hepatitis
    • a. Hepatitis A
    • b. Hepatitis B
    • c. Hepatitis C
    • d. Hepatitis D
  • 13. Herpes Simplex Virus
  • 14. Human Herpes Virus-6 (HHV-6)
  • 15. Influenza Viruses
  • 16. Legionella
  • 17. Lyme Disease
  • 18. Measles (Rubeola)
  • 19. Meningitis
  • 20. Mononucleosis
  • 21. Mumps
  • 22. Mycoplasma
  • 23. Papillomaviruses
  • 24. Pneumonia
  • 25. Respiratory Syncytial Virus (RSV)
  • 26. Rheumatoid Arthritis
  • 27. Rotavirus (Reovirus)
  • 28. Rubella (German Measles)
  • 29. Salmonellosis
  • 30. Shigellosis
  • 31. Staphylococcus Aureus
  • 32. Streptococci
  • 33. Syphilis

Tumor Markers

  • 1. Alpha-Fetoprotein (AFP)
  • 2. Carcinoembrionic Antigen (CEA)
  • 3. Occult Blood
  • 4. Prostatic Acid Phosphatase (PAP)
  • 5. Prostate-Specific Antigen (PSA)

Major Routine and Special Hematology Tests

  • 1. CBC Analysis
    • a. Hemoglobin Concentration
    • b. Hematocrit Determination
    • c. Red Blood Cell Count
    • d. Platelets

Endocrine Function Tests

  • 1. Cortisol
  • 2. Follicle-Stimulating Hormone (FSH)
  • 3. Gastrin
  • 4. Human Chorionic Gonadotropin (HCG)
  • 5. LH
  • 6. Prolactin
  • 7. T3
  • 8. T3 Uptake
  • 9. Free T3
  • 10. Thyroxine (T4)
  • 11. Free T4
  • 12. TBG
  • 13. TSH

Therapeutic Drug Monitoring (TDM)

  • 1. Overview
  • 2. Carbamazepine
  • 3. Digoxin
  • 4. Gentamicin
  • 5. Lidocaine
  • 6. Lithium
  • 7. Phenytoin/Dilantin
  • 8. Procainamide
  • 9. Quinidine
  • 10. Theophylline
  • 11. Valproic Acid

Coagulation Tests

  • 1. Introduction
  • 2. Activated Partial Thromboplastin Time (APTT)
  • 3. Alpha-2 Antiplasmin
  • 4. Antithrombin III
  • 5. Bleeding Time
  • 6. D-Dimer
  • 7. Factor VIII
  • 8. Fibrin Degradation Products
  • 9. Fibrinogen
  • 10. Heparin
  • 11. Proteins C and S
  • 12. Prothrombin Time (PT)
  • 13. Thrombin Time

Immunoprotein Tests

  • 1. CRP
  • 2. Immunoglobulins

Drugs of Abuse

  • 1. Overview
  • 2. Test Methodologies
  • 3. Amphetamines
  • 4. Barbiturates
  • 5. Benzodiazepines
  • 6. Cannabinoids/Marijuana
  • 7. Cocaine
  • 8. Lysergic Acid Diethylamide (LSD)
  • 9. Methadone
  • 10. Methaqualone
  • 11. Opiates
  • 12. Phencyclidine

Instrumentation

  • 1. Chemistry Analyzers Manufactured by:
    • Abaxis
    • Abbott
    • Alfa Wassermann
    • Awareness Technologies
    • Beckman Coulter/Danaher
    • bioMeriuex
    • Carolina Chemistries
    • Horiba
    • Inverness
    • Medica
    • Nova Biomedical
    • Ortho-Clinical Diagnostics
    • Polimedco
    • Randox
    • Roche
  • 2. Hematology Analyzers Manufactured by:
    • Abbott
    • Becton Dickinson
    • Beckman Coulter/Danaher
    • Biocode
    • Drew-Scientific
    • Diesse Ves Matic
    • Horiba
    • Menarini
    • Nihon Kohden
    • Polymedco
    • Sysmex
  • 3. Coagulation Analyzers Manufactured by:
    • Behnk Elektronik
    • Bio/Data
    • Cardiovascular Diagnostics
    • Diagnostica Stago
    • Helena Laboratories
    • Instrumentation Laboratory
    • ITC Hemochron
    • Roche
    • Siemens
    • Sysmex
    • Teco Medical Instruments
    • Trinity Biotech

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

Worldwide Business Environment

U.S.A.

  • A. Market Overview
    • 1. Business Environment
      • a. Health Care Expenditures
      • b. Cost Consciousness
      • c. Reimbursement
      • d. Industry Consolidation
      • e. Managed Care
        • PPO
        • HMO
      • f. Hospitals
      • g. Admissions
      • h. Length of Stay
      • i. Industry Diversification
      • j. Physician Demographics
      • k. Aging Population
        • More Chronic Illness
        • Disease Incidence
        • Susceptibility to latrogenesis
        • Multiple Illnesses Cases
      • l. Laboratory Regulations
    • 2. Market Structure
      • a. Hospitals
      • b. Commercial/Private Laboratories
  • B. Physician Offices/Group Practices
    • 1. Market Summary
    • 2. Market Structure
    • 3. Test Volume and Sales Forecasts
  • C. Major Suppliers' Instrument Placements, Installed Base, Consumables Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • ADI/America Diagnostica
  • Agilent Technologies
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Biomerieux
  • Bio-Rad
  • Biosite/Inverness/Alere
  • Cepheid
  • Chrono-Log
  • Corgenix
  • Decode
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Diasorin
  • Eiken Chemical
  • EKF Diagnostics
  • Fujirebio/Innogenetics
  • Helena Laboratories
  • Hologic/Gen-Probe
  • Horiba
  • Instrumentation Laboratory
  • International Technidyne/Nexus DX
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Lonza
  • Mackay Life Sciences
  • Matritech
  • Nihon Kohden
  • Ortho-Clinical Diagnostics
  • Polartechnics
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • Sysmex
  • Takara Bio
  • ThermoFisher
  • Tosoh
  • Wako
  • Zycare/Alere

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing APTT Tests
  • Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
  • Major Companies Developing or Marketing Antithrombin III Tests
  • Major Companies Developing or Marketing Bleeding Time Tests
  • Major Companies Developing or Marketing D-Dimer Tests
  • Major Companies Developing or Marketing Factor Assays Tests
  • Major Companies Developing or Marketing Fibrin Degradation Product Tests
  • Major Companies Developing or Marketing Fibrinogen Tests
  • Major Companies Developing or Marketing Heparin Tests
  • Major Companies Developing or Marketing Protein C Tests
  • Major Companies Developing or Marketing Protein S Tests
  • Major Companies Developing or Marketing PT Tests
  • Major Companies Developing or Marketing Thrombin Time Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • U.S.A., Physician Offices/Group Practices Total Diagnostic Sales Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Reagent Sales Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Instrument Sales Forecast by Market Segment
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Physician Offices Laboratories Major Infectious Disease Test Volume Forecast
  • U.S.A., Physician Offices/Group Practice Microbiology Test Volume Forecast by Market Segment
  • U.S.A., Physician Offices/Group Practices Routine Hematology Test Volume Forecast
  • U.S.A., Physician Offices Laboratories Flow Cytometry and Special Hematology Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Coagulation Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Microbiology/Infectious Disease Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Physician Offices Laboratories Major Infectious Disease Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Microbiology Reagent Market Forecast By Market Segment
  • U.S.A., Physician Offices/Group Practices Hematology and Flow Cytometry Consumables Market Forecast
  • U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Coagulation Reagent Market Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Major Suppliers of Clinical Chemistry Reagents: Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Analyzers: Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Immunodiagnostic Products: Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Immunoassay Reagents: Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Immunoassay Analyzers: Estimated Sales and Market Shares
  • U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., AFP Testing Market by Major Suppliers
  • U.S.A., CA 15-3/27-29 Testing Market by Major Suppliers
  • U.S.A., CA 19-9 Testing Market by Major Suppliers
  • U.S.A., CEA Testing Market by Major Suppliers
  • U.S.A., PAP Testing Market by Major Suppliers
  • U.S.A., PSA Testing Market by Major Suppliers
  • U.S.A., Hematology Analyzers Estimated Placements and Installed Base
  • U.S.A., Flow Cytometers Estimated Placements and Installed Base
  • U.S.A., Hematology Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Instrument Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hematology Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Diagnostics Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Consumable Market Estimated Market Shares of Major Suppliers
  • U.S.A., Flow Cytometry Instruments Market Estimated Market Shares of Major Suppliers
  • U.S.A., Market Major Suppliers of Coagulation Diagnostic Products, Estimated Market Shares of Major Suppliers
Back to Top